Publication | Closed Access

In vitro, ex vivo and in vivo immunopharmacological activities of the isoxazoline compound VGX-1027: Modulation of cytokine synthesis and prevention of both organ-specific and systemic autoimmune diseases in murine models

InflammationCytokineSystemic Autoimmune DiseasesAutoimmune DiseaseMedicineImmunologyMurine ModelsAutoimmunityImmunosuppressionImmunopathologyImmunotherapyPharmacologyIsoxazoline Compound Vgx-1027